Genetic Disorders

Jan 07, 2025

Chimerix Submits Dordaviprone NDA for Accelerated Approval in Recurrent H3 K27M-Mutant Diffuse Glioma to FDA; NMD Pharma’s NMD670 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease; Verastem’s Avutometinib NDA Accepted for KRAS Mutant Ovarian Cancer; Capricor Submits BLA for Deramiocel in Duchenne Muscular Dystrophy; Axsome Completes Phase III Trial of AXS-05 for Alzheimer’s Agitation

Jan 03, 2024

DNA Sequencing Market: Unveiling Innovations and Key Trends Shaping the Market Growth

Apr 20, 2022

Top 12 Most Expensive Drugs in the US Healthcare Market

Mar 21, 2022

Role of Mobile Technology in Hemophilia Management

Jan 14, 2015

DelveInsight’s Gene Therapy Reports: Launched

Jan 07, 2015

Gene Therapy’s Emergence: The “New” approach for Huntington’s disease

Jan 06, 2015

Are you ready to embrace Gene Therapy?

Dec 22, 2014

DelveInsight’s Genetic disorders based Gene Therapy Reports

Dec 17, 2014

Break the Gene Therapy Barrier with DelveInsight’s Gene Therapy Reports

Dec 05, 2014

Gene Therapy Market

Newsletter/Whitepaper